Sermorelin acetate

This classification denotes a growth hormone-releasing hormone analogue with the molecular formula C149H246N44O42S.C2H4O2.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 00IBG87IQW, chemically known as 29-l-argininamide-30-de-l-glutamine-31-de-l-glutamine-32-deglycine-33-de-l-glutamic acid-34-de-l-serine-35-de-l-asparagine-36-de-l-glutamine-37-de-l-glutamic acid-38-de-l-arginine-39-deglycine-40-de-l-alanine-41-de-l-arginine-42-de-l-alanine-43-de-l-arginine-44-de-l-leucinamidegrowth hormone-releasing factor (human pancreatic islet), acetate (salt), hydrate but generally known as sermorelin acetate, which bears US NIH Compound Identifier 16132412. European Medicines Agency schedules Sermorelin acetate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04370MIG. Most nations schedule sermorelin acetate under HS 29371900 and SITC 54154. As of Q4 2014, SERMORELIN ACETATE remains the US FDA Preferred Term for this commodity. Sermorelin acetate bears US NLM identifiers UMLS ID C0720660 and NCI Concept Code C47715. SMILES: S(CCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(N)CC1CCC(O)CC1)C)CC(=O)O)C)C(CC)C)CC1CCCCC1)C(O)C)CC(=O)N)CO)CC1CCC(O)CC1)CCCNC(=N)N)CCCCN)C(C)C)CC(C)C)CCC(=O)N)CC(C)C)CO)C)CCCNC(=N)N)CCCCN)CC(C)C)CC(C)C)CCC(=O)N)CC(=O)O)C(CC)C)C(=O)NC(CO)C(=O)NC(CCCNC(=N)N)C(=O)N)C.OC(=O)C.